Written by and for nurse practitioners, and also well suited for physician’s assistant students, this practical textbook focuses on what primary care providers need to know in order practice safe and effective drug therapy. With an overall emphasis on patient teaching and health promotion, Edmunds & Mayhew teaches students and practitioners how to provide effective patient teaching about medications and how to promote adherence to prescribed drug regimens. Drug coverage focuses on "key drugs" - those most commonly used and most representative of each major drug class - with particular emphasis on the top 100 most commonly prescribed drugs. The book also features integrated coverage of nationally accepted clinical and evidence-based practice guidelines. The new 4th edition features a completely new full-color design and illustration program;; coverage of new drugs, new drug classes, and new therapeutic drug uses; updated coverage of the latest national clinical and evidence-based treatment guidelines; newly integrated and highlighted coverage of drug-herb interactions; an expanded emphasis on safety and evidence-based practice, consistent with the QSEN initiative, retooled "Safety Alert!" and "Clinical Practice Alert!" highlights; expanded and an enhanced ancillary package emphasizing graduate-level QSEN KSAs and new pharmacology-focused ArchieMD animations.
New to This Edition
UNIQUE! Full-color design and illustrations: The 4th edition features an all-new full-color design and illustration program that highlights the content that is most important for primary care prescribers to know.
New drugs, drug classes, and therapeutic uses: The new edition is updated throughout to reflect the very latest FDA-approved drugs, drug classes, and therapeutic uses. Coverage of older, lesser-used drugs have been reduced or eliminated, and FDA-withdrawn drugs have been removed.
Updated coverage of the latest national clinical and evidence-based treatment guidelines: The book is updated throughout to reflect the very latest national clinical practice guidelines and evidence-based treatment guidelines to ensure that students are equipped with the most up-to-date evidence-based prescribing information. In particular, the 4th edition includes the new JNC8 guidelines for treatment of hypertension and the latest clinical treatment guidelines for diabetes, which change frequently.
Integrated and highlighted coverage of drug-herb and other alternative therapy interactions: To supplement the book’s complementary and alternative therapies chapter (Chapter 8), clinically significant drug-herb/supplement interaction tables will be added throughout chapters and highlighted with a distinctive icon.
Expanded emphasis on safety and evidence-based practice, consistent with QSEN: To address the growing problem of drug errors and to better align the book with the Quality and Safety Education for Nurses (QSEN) initiative, the book’s emphasis on safe drug administration is enhanced with retooled, color-highlighted "Safety Alert!" and "Clinical Practice Alert!" features (formerly "Clinical Landmine"). The 4th edition also features a greater emphasis on the QSEN competency of evidence-based practice, with frequent reference throughout to reliance on the best research evidence.
Reduced coverage of drugs not commonly seen in primary care: The new edition features reduced coverage of drugs not commonly seen in primary care.. This will allow an increased focus on need-to-know drug content for primary care practice.
7. Enhanced ancillary package emphasizing graduate-level QSEN KSAs : Enrollments in graduate-level nursing programs are surging dramatically, particularly in DNP programs. According to AACN, "In just five years, the number of schools offering the DNP has increased from 20 programs in 2006 to 153 programs in 2010, with another 106 programs in the planning stages. Last year [2010], enrollment in these programs grew by 35.3% with 7,034 students now enrolled in DNP programs" (AACN, available at http://www.aacn.nche.edu/Media/NewsReleases/2011/enrollsurge.html). According to Marilyn Edmunds, however, one result of this growth is a severe shortage of faculty in NP programs, leaving inexperienced faculty in dire need of limited but high-quality ancillary resources. The ancillary package for the 4th edition has been enhanced by revamping and expanding the existing Test Bank to improve the quality and number of questions.Improved chapter-opening Drug Overview tables: The Drug Overview tables, which serve as an advance organizer at the start of each chapter, have been enhanced with more intuitive "Top 100" icons that highlight the most commonly prescribed drugs, as well as an improved, colorful graphic design.
~
Key Features
New Features
UNIQUE! Full-color design and illustrations: The 4th edition features an all-new full-color design and illustration program that highlights the content that is most important for primary care prescribers to know.
New drugs, drug classes, and therapeutic uses: The new edition is updated throughout to reflect the very latest FDA-approved drugs, drug classes, and therapeutic uses. Coverage of older, lesser-used drugs have been reduced or eliminated, and FDA-withdrawn drugs have been removed.
Updated coverage of the latest national clinical and evidence-based treatment guidelines: The book is updated throughout to reflect the very latest national clinical practice guidelines and evidence-based treatment guidelines to ensure that students are equipped with the most up-to-date evidence-based prescribing information. In particular, the 4th edition includes the new JNC8 guidelines for treatment of hypertension and the latest clinical treatment guidelines for diabetes, which change frequently.
Integrated and highlighted coverage of drug-herb and other alternative therapy interactions: To supplement the book’s complementary and alternative therapies chapter (Chapter 8), clinically significant drug-herb/supplement interaction tables will be added throughout chapters and highlighted with a distinctive icon.
Expanded emphasis on safety and evidence-based practice, consistent with QSEN: To address the growing problem of drug errors and to better align the book with the Quality and Safety Education for Nurses (QSEN) initiative, the book’s emphasis on safe drug administration is enhanced with retooled, color-highlighted "Safety Alert!" and "Clinical Practice Alert!" features (formerly "Clinical Landmine"). The 4th edition also features a greater emphasis on the QSEN competency of evidence-based practice, with frequent reference throughout to reliance on the best research evidence.
Reduced coverage of drugs not commonly seen in primary care: The new edition features reduced coverage of drugs not commonly seen in primary care.. This will allow an increased focus on need-to-know drug content for primary care practice.
7. Enhanced ancillary package emphasizing graduate-level QSEN KSAs : Enrollments in graduate-level nursing programs are surging dramatically, particularly in DNP programs. According to AACN, "In just five years, the number of schools offering the DNP has increased from 20 programs in 2006 to 153 programs in 2010, with another 106 programs in the planning stages. Last year [2010], enrollment in these programs grew by 35.3% with 7,034 students now enrolled in DNP programs" (AACN, available at http://www.aacn.nche.edu/Media/NewsReleases/2011/enrollsurge.html). According to Marilyn Edmunds, however, one result of this growth is a severe shortage of faculty in NP programs, leaving inexperienced faculty in dire need of limited but high-quality ancillary resources. The ancillary package for the 4th edition has been enhanced by revamping and expanding the existing Test Bank to improve the quality and number of questions.Improved chapter-opening Drug Overview tables: The Drug Overview tables, which serve as an advance organizer at the start of each chapter, have been enhanced with more intuitive "Top 100" icons that highlight the most commonly prescribed drugs, as well as an improved, colorful graphic design.
Key Features Retained
Nurse practitioner focus: Written by Nurse practitioners for Nurse practitioners (as well as PAs), with an overall emphasis on patient teaching and health promotion, Edmunds & Mayhew focuses on the kinds of information that primary care providers need to know.
Key drug approach: A "key drug" approach enables students to focus on the most representative, commonly used drugs in each class to promote learning of need-to-know information.
Drug Overview tables: Drug Overview tables at the start of each chapter summarize key drugs for each chapter as an advance organizer and conceptual framework for each chapter.
Emphasis on the "Top 100" most prescribed drugs: Focuses valuable teaching and study time on the most important, need-to-know drug information
Consistent chapter organization: A consistent organization from chapter to chapter facilitates understanding and learning of key concepts.
Highlighted content on patient teaching and drug adherence: Highlighted content on patient teaching and adherence to the drug regimen emphasizes the primary care provider’s role in patient teaching, an increasingly integral role in an era when patients and caregivers are now being called upon to do more to manage their own health.
Drug therapy for special populations: Extensive coverage of drug therapy for special populations (e.g., geriatric, pediatric) x_alerts the primary care provider to special considerations based on age, pregnancy, race, etc.
Emphasis of health promotion: Consistent with the health promotion emphasis that is characteristic of nurse practitioners in the primary care setting, the book emphasizes how to help patients stay well and improve their health, as well as preparing practitioners to treat illness with drug therapy.
Clinical x_alerts: "Safety Alert!" and "Clinical Practice Alert! features (formerly "Clinical Landmines") highlight essential safety and clinical practice information that primary care providers must remember in order to practice safely and effectively.
PART ONE - ESSENTIAL CONCEPTS FOR THE PRESCRIPTION OF MEDICATIONS
Unit 1 Foundations of Prex_scriptive Practice
Ch. 1 Prex_scriptive Authority and Role Implementation: Tradition vs. Change
Ch. 2 Historical Review of Prex_scriptive Authority: The Role of Nurses (NPs, CNMs, CRNAs, and CNSs) and Physician Assistants
Unit 2 Pharmacokinetics and Pharmacodynamics
Ch. 3 General Pharmacokinetic and Pharmacodynamic Principles
Ch. 4 Special Populations: Geriatrics
Ch. 5 Special Populations: Pediatrics
Ch. 6 Special Populations: Pregnant and Nursing Women
Ch. 7 Over-the-Counter Medications
Ch. 8 Complementary and Alternative Therapies
Unit 3 The Art and Science of Pharmacotherapeutics
Ch. 9 Establishing the Therapeutic Relationship
Ch.10 Practical Tips on Writing Prex_scriptions
Ch.11 Evidence-Based Decision-Making and Treatment Guidelines
Ch.12 Design and Implementation of Patient Education
PART TWO - DRUG MONOGRAPHS
Unit 4 Topical Agents
Ch. 13 Dermatologic Agents
Ch. 14 Eye, Ear, Throat, and Mouth Agents
Unit 5 Respiratory Agents
Ch. 15 Upper Respiratory Agents
Ch. 16 Asthma and Chronic Obstructive Pulmonary Disease Medications
Unit 6 Cardiovascular Agents
Ch. 17 Hypertension and Miscellaneous Antihypertensive Medications
Ch. 18 Coronary Artery Disease and Antianginal Medications
Ch. 19 Heart Failure and Digoxin
Ch. 20 ß-Blockers
Ch. 21 Calcium Channel Blockers
Ch. 22 ACE Inhibitors and Angiotensin Receptor Blockers
Ch. 23 Antiarrhythmic Agents
Ch. 24 Antihyperlipidemic Agents
Ch. 25 Agents that Act on Blood
Unit 7 Gastrointestinal Agents
Ch. 26 Antacids and the Management of GERD
Ch. 27 Histamine-2 Blockers and Proton Pump Inhibitors
Ch. 28 Laxatives
Ch. 29 Antidiarrheals
Ch. 30 Antiemetics
Ch. 31 Medications for Irritable Bowel Syndrome and Other Gastrointestinal Problems
Unit 8 Renal/Genitourinary Agents
Ch. 32 Diuretics
Ch. 33 Male Genitourinary Agents
Ch. 34 Drugs for Urinary Incontinence and Urinary Analgesia
Unit 9 Musculoskeletal Agents
Ch. 35 Acetaminophen
Ch. 36 Aspirin and Nonsteroidal Antiinflammatory Drugs
Ch. 37 Disease-Modifying Antirheumatic Drugs and Immune Modulators
Ch. 38 Gout Medications
Ch. 39 Osteoporosis Treatment
Ch. 40 Muscle Relaxants
Unit 10 Central Nervous System Agents
Ch. 41 Medications for Attention Deficit Hyperactivity Disorder
Ch. 42 Medications for Dementia
Ch. 43 Analgesia and Pain Management
Ch. 44 Migraine Medications
Ch. 45 Antiepileptics
Ch. 46 Antiparkinson Agents
Unit 11 Psychotropic Agents
Ch. 47 Antidepressants
Ch. 48 Antianxiety and Antiinsomnia Agents
Ch. 49 Antipsychotics
Ch. 50 Substance Abuse
Unit 12 Endocrine Agents
Ch. 52 Glucocorticoids
Ch. 52 Thyroid Medications
Ch. 53 Diabetes Mellitus Agents
Unit 13 Female Reproductive System Medications
Ch. 54 Contraceptives
Ch. 55 Hormone Replacement Therapy
Ch. 56 Drugs for Breast Cancer
Unit 14 Antiinfectives
Ch. 57 Principles for Prescribing Antiinfectives
Ch. 58 Treatment of Specific Infections and Miscellaneous Antibiotics
Ch. 59 Penicillins
Ch. 60 Cephalosporins
Ch. 61 Tetracyclines
Ch. 62 Macrolides
Ch. 63 Fluoroquinolones
Ch. 64 Aminoglycosides
Ch. 65 Sulfonamides
Ch. 66 Antitubercular Agents
Ch. 67 Antifungals
Ch. 68 Antiretroviral Drugs
Ch. 69 Antiviral and Antiprotozoal Agents
Unit 15 Health Promotion
Ch. 70 Immunizations and Biologicals
Ch. 71 Weight Management
Ch. 72 Smoking Cessation
Ch. 73 Vitamins and Minerals
구분 | 13시 이전 | 13시 이후 |
---|---|---|
군자도서 | 당일출고 | 1일 추가 |
타사도서 | 1일 ~ 2일 추가 | 2일 ~ 3일 추가 |
고객님께서 급히 필요하신 상품은 별도로 나누어 주문하시면 수령시간이 절약됩니다.
국내에서 재고를 보유한 업체가 없는 경우 해외주문을 해야 하는 상황이 생깁니다.
이 경우 4~5주 안에 공급이 가능하며 현지 출판사 사정에 따라 구입이 어려운 경우 2~3주 안에 공지해 드립니다.
# 재고 유무는 주문 전 사이트 상에서 배송 안내 문구로 구분 가능하며, 필요에 따라 전화 문의 주시면 거래처를 통해 다시 한번 국내재고를 확인해 드립니다.
전자상거래에 의한 소비자보호에 관한 법률에 의거 반품 가능 기간내에는 반품을 요청하실 수 있습니다.
(10881) 경기도 파주시 회동길 338 (서패동 474-1) 군자출판사빌딩 4층